Could treating sleep apnea help veterans beat PTSD and addiction?

NCT ID NCT05156112

First seen Nov 03, 2025 · Last updated Jun 20, 2026 · Updated 32 times

Summary

This study looks at whether treating obstructive sleep apnea (OSA) early with a positive airway pressure (PAP) device can improve outcomes for veterans with both PTSD and substance use disorder. About 194 veterans in a residential treatment program will either receive PAP therapy right away or be placed on a waitlist. Researchers will measure changes in daily functioning, substance use, PTSD symptoms, and suicidal thoughts over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VA San Diego Healthcare System, San Diego, CA

    RECRUITING

    San Diego, California, 92161-0002, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Positive Airway Pressure (PAP) device

What this could lead to

If it works, this could point toward a way to improve mental health and substance use outcomes by treating sleep apnea early in residential treatment.

What could go wrong

This is a relatively small, early-stage study with no blinding, so results may not be conclusive or generalizable. PAP adherence can be low, which could limit effectiveness.

Conditions

The condition(s) this trial relates to.

obstructive sleep apnea syndrome post-traumatic stress disorder substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.